TEVA PHARMACEUTICAL FIN CO's ticker is and the CUSIP is 88165FAF9. A total of 1 filers reported holding TEVA PHARMACEUTICAL FIN CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $28,000 | 0.0% | 28,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $28,000 | 0.0% | 28,000 | 0.0% | 0.01% | -6.7% |
| Q1 2021 | $28,000 | 0.0% | 28,000 | 0.0% | 0.02% | -6.2% |
| Q4 2020 | $28,000 | 0.0% | 28,000 | 0.0% | 0.02% | -5.9% |
| Q3 2020 | $28,000 | 0.0% | 28,000 | 0.0% | 0.02% | -5.6% |
| Q2 2020 | $28,000 | +3.7% | 28,000 | 0.0% | 0.02% | -5.3% |
| Q1 2020 | $27,000 | 0.0% | 28,000 | 0.0% | 0.02% | +18.8% |
| Q4 2019 | $27,000 | +3.8% | 28,000 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $26,000 | -3.7% | 28,000 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $27,000 | 0.0% | 28,000 | 0.0% | 0.02% | -5.9% |
| Q1 2019 | $27,000 | +92.9% | 28,000 | +86.7% | 0.02% | +88.9% |
| Q4 2018 | $14,000 | -6.7% | 15,000 | 0.0% | 0.01% | +12.5% |
| Q3 2018 | $15,000 | +7.1% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $14,000 | 0.0% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $14,000 | 0.0% | 15,000 | 0.0% | 0.01% | -20.0% |
| Q4 2017 | $14,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Highlander Capital Management, LLC | 28,000 | $28,000 | 0.02% |